Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2007
03/15/2007WO2006136951A3 Murine stem cells and applications thereof
03/15/2007WO2006136244A3 Use of adipose tissue-derived stromal stem cells in treating fistula
03/15/2007WO2006133164A3 Anti-trkb monoclonal antibodies and uses thereof
03/15/2007WO2006127152A3 Methods for making and using regulatory t cells
03/15/2007WO2006127150A3 Dendritic cell compositions and methods
03/15/2007WO2006126025A3 Cytokine
03/15/2007WO2006121422A3 Antibodies against clostridium difficile toxins and uses thereof
03/15/2007WO2006107601A3 Parathyroid and thymus transplantation in digeorge syndrome subjects
03/15/2007WO2006099451A3 Novel human, feline, chicken and other animal interferons and uses thereof
03/15/2007WO2006088951A3 Cd38 modulated chemotaxis
03/15/2007WO2006068481A3 Novel necrosis and ethylene inducing proteins from botrytis
03/15/2007WO2006055841A3 Indefinite culture of human adult glia without immortalization and therapeutic uses thereof
03/15/2007WO2006055685A3 Transplantation of human neural cells for treatment of neurodegenerative conditions
03/15/2007WO2006052534A3 Expansion of nk cells and therapeutic uses thereof
03/15/2007WO2006042049A3 Oil and seeds with reduced saturate levels of fatty acids
03/15/2007WO2006015214A3 Umbilical cord stem cell composition & method of treating neurological diseases
03/15/2007WO2004072100A3 Nell peptide expression systems and bone formation activity of nell peptide
03/15/2007WO2003082006A3 Methods and compositions for preventing obesity and obesity related disorders
03/15/2007WO2003074659A3 Magnetic immobilization of cells
03/15/2007US20070061923 Polypeptides having antimicrobial activity and polynucleotides encoding same
03/15/2007US20070061921 Transgenic cells
03/15/2007US20070061920 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
03/15/2007US20070061919 Lepidopteran-active bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use
03/15/2007US20070061918 Method for modifying gene expression of a phytopathogenic fungus
03/15/2007US20070061917 Methods and compositions for the expression of a polynucleotide of interest
03/15/2007US20070061914 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
03/15/2007US20070061912 Method for obtaining improved fertility restorer lines for transgenic male sterile crop plants and a dna construct for use in said method
03/15/2007US20070061910 Method for culturing avian spermatogonial stem cells and avian spermatogonial stem cells prepared thereby
03/15/2007US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators
03/15/2007US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors
03/15/2007US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators
03/15/2007US20070061903 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste
03/15/2007US20070061902 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste
03/15/2007US20070061901 Methods to inhibit growth of prostate cancer cells
03/15/2007US20070061900 Methods of modifying eukaryotic cells
03/15/2007US20070060742 for new human tumor necrosis factor receptor designated as Ztnfr12; usefulness in both basic research and as therapeutics
03/15/2007US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy
03/15/2007US20070059836 Genetic engineering; preventing the proliferation of neoplastic cells; cancer;
03/15/2007US20070059832 by electroporation; efficient introduction of a gene into cells, gene introduction at desirable timing and at desirable sites can be performed without damaging the adhering cells
03/15/2007US20070059830 Method for creating myeloid cell lines
03/15/2007US20070059827 Device for the regeneration of tissue, specifically bone regeneration by means of callus distraction
03/15/2007US20070059826 Method to Preserve Cells
03/15/2007US20070059825 Cytokine zalpha11 ligand antibodies
03/15/2007US20070059824 Human umbilical cord blood-derived pluripotent fibroblast-like-macrophages
03/15/2007US20070059823 Neuronal differentiation of stem cells
03/15/2007US20070059822 Method for isolating cells from mammary secretion
03/15/2007US20070059821 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents
03/15/2007US20070059805 Method for producing saccharide chain-extended chondroition
03/15/2007US20070059800 Novel peptide, novel adsorbent, adsorption unit and adsorption method
03/15/2007US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
03/15/2007US20070059767 Method of identifying N-terminal proBNP
03/15/2007US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators
03/15/2007US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
03/15/2007US20070059721 MAGI polynucleotides, polypeptides, and antibodies
03/15/2007US20070059689 Hybrid glycosylated products and their production and use
03/15/2007US20070059688 Gastrointestinal chemosensory receptors
03/15/2007US20070059687 Process for evaluating phagocytotic function and use thereof
03/15/2007US20070059345 Method for tissue growth
03/15/2007US20070059335 Seeding implantable medical devices with cells
03/15/2007US20070059325 Genetic vaccine against PWD circovirus
03/15/2007US20070059324 Circovirus sequences associated with piglet weight loss disease (PWD)
03/15/2007US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE)
03/15/2007US20070059307 Biological products
03/15/2007US20070059305 Neutralizing human anti-IGFR antibody
03/15/2007US20070059294 Therapeutiv preparation for hematopoietic disease
03/15/2007US20070059293 Tissue engineered construct for supplementing or replacing a damaged organ
03/15/2007US20070059291 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
03/15/2007US20070059290 Transcriptional regulation of target genes
03/15/2007US20070059287 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
03/15/2007US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent
03/15/2007US20070056597 Transplantation of human lipid cells and other tissue regenerative cells and methods of use ancillary to sports/entertainment/celebrity/performance employment contracts and policies insuring those contracts
03/15/2007DE102005040816A1 Preparing capillary-structured neural implant, useful for regenerating degenerated neural tissue, comprises contacting sodium alginate sol with multivalent cation solution and forming thin membrane in boundary region between two liquids
03/15/2007CA2808659A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
03/15/2007CA2808179A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
03/15/2007CA2629405A1 Tissue engineering methods and compositions
03/15/2007CA2621973A1 Chimeric hcn channels
03/15/2007CA2621386A1 An embedding method and apparatus for the preparation of frozen section tissue
03/15/2007CA2621161A1 Methods for promoting stem cell proliferation and survival
03/15/2007CA2620136A1 Sequence capable of enhancing the expression of gene under moderately low temperature
03/14/2007EP1762617A1 Method for manufacturing recombinant polyclonal proteins
03/14/2007EP1762611A1 Nucleic acid/enzyme complex
03/14/2007EP1762609A2 Serum-free medium for producing substances of interest
03/14/2007EP1762244A1 Bmp-9 compositions for inducing differentiation of cholinergic neurons
03/14/2007EP1761635A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof
03/14/2007EP1761627A1 Cell-based therapies for ischemia
03/14/2007EP1761561A2 Antibody specificity transfer using minimal essential binding determinants
03/14/2007EP1761557A1 Novel gene products from bacillus licheniformis forming or decomposing polyamino acids and improved biotechnological production methods based thereon
03/14/2007EP1623031A4 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar.
03/14/2007EP1397681B1 Method for identification of agents for the treatment of diabetes
03/14/2007EP1387891B1 Compounds and methods for inhibiting axillary malodour
03/14/2007EP1343897B1 Purified active hcv ns2/3 protease
03/14/2007EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
03/14/2007EP1325956B1 Plant lesion formation suppressing gene, spl7 and use theriof
03/14/2007EP1305434B1 A human disintegrin protein
03/14/2007EP1298991A4 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
03/14/2007EP1226169B1 Molecular structure of rhd negative locus
03/14/2007EP1224302B1 Modified viral surface proteins which bind to cells of tumor vasculature
03/14/2007EP1112351B1 Polymerase chimeras
03/14/2007EP1098979B1 Antibody with improved producibility
03/14/2007EP1007697B1 Production of proteins in eggs
1 ... 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 ... 1827